SRRK Q2 2024 Earnings — Scholar Rock Holding Corporation Revenue & Financial Results | Market Cap Arena

SRRKScholar Rock Holding Corporation

$5B

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$498,000

Operating Income

-$59M

Net Income

-$59M

EPS (Diluted)

$-0.60

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$49M

Free Cash Flow

-$49M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$227M

Total Liabilities

$93M

Stockholders' Equity

$134M

Cash & Equivalents

$93M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$498,000	-$3M	+80.7%
Operating Income	-$59M	-$39M	-52.2%
Net Income	-$59M	-$38M	-54.3%